Women's health
Follitropin alfa (recombinant human follicle stimulating hormone)
Gonadotropin; Ovulation Stimulator; Recombinant human follicle stimulating hormone
Other names: Gonal-F
Wait
7 days
after the first dose
The FAA's MedGuide lists follitropin alfa (recombinant human follicle stimulating hormone) (Gonal-F) as allowed, for infertility, in-vitro fertilization (IVF) or spermatogenesis, with a wait of 7 days after the first dose and none after later doses or after the final dose, used as prescribed.
Track your medicationsMore detail: follitropin alfa (recombinant human follicle stimulating hormone)The rest of Crosscheck's reading, in plain wordsOpen
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
- 7 days after the first dose: ground observation
Show the FAA's words: follitropin alfa (recombinant human follicle stimulating hormone)The official FAA wording: three passages, each with its document and dateOpen
Generic: follitropin alfa (recombinant human follicle stimulating hormone)
Brand Name: Gonal-F
Drug Class: Gonadotropin; Ovulation Stimulator; Recombinant human follicle stimulating hormone
Underlying Condition: Infertility; In-vitro fertilization (IVF); Spermatogenesis
Use: ALLOW
INITIAL Wait Time (after first dose): 7 days
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.